Fertility and Sterility
Volume 93, Issue 2 , Pages 537-543, 15 January 2010

The human ovarian follicular fluid level of interleukin-8 is associated with follicular size and patient age

  • Beth A. Malizia, M.D.

      Affiliations

    • Boston IVF, Waltham, Massachusetts
    • Division of Reproductive Endocrinology and Infertility, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
  • ,
  • Yoo Sang Wook, M.D., Ph.D.

      Affiliations

    • Department of Medicine and Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
  • ,
  • Alan S. Penzias, M.D.

      Affiliations

    • Boston IVF, Waltham, Massachusetts
    • Division of Reproductive Endocrinology and Infertility, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
  • ,
  • Anny Usheva, Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Department of Medicine and Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationReprint requests: Anny Usheva, Ph.D., Beth Israel Deaconess Medical Center 3 Blackfan Circle, CLS 701, Boston, MA 02215.

Received 24 September 2008; received in revised form 8 November 2008; accepted 25 November 2008. published online 16 March 2009.

Objective

To investigate the relationship between interleukin-8 (IL-8) in the human ovarian follicle and follicular size, patient age, and fertility factors in IVF cycles.

Design

Prospective study.

Setting

University hospital research laboratory and infertility clinic.

Patient(s)

Women undergoing IVF with oocyte retrieval.

Intervention(s)

Follicular fluid (FF) aspiration, oocyte isolation, FF storage, and experimental studies.

Main Outcome Measure(s)

Quantization of IL-8 by ELISAs and protein microarray; high-performance liquid chromatography (HPLC) followed by ELISA and Western blotting to evaluate α2-macroglobulin (α2M) bound IL-8; association of IL -8 to follicular size, patient age, and IVF outcomes.

Result(s)

Samples of FF from 63 patients contained an average of 629.59 pg/mL of IL-8 with 50%–70% bound to α2M. Large follicles contained higher levels of IL-8 than small follicles (937.34 vs. 86.97 pg/mL). The IL-8 concentration in the large follicles of women of young age was higher than that of older reproductive age women (1,373.61 vs. 673.29 pg/mL). There were no statistically significant associations found between IL-8 concentration and other IVF cycle factors or pregnancy outcome.

Conclusion(s)

Our findings indicate that IL-8 is present in FF, both in its free and α2M-bound state, and its concentration is correlated with follicular size and patient age.

Key Words: Cytokines, interleukin-8 (IL-8), follicular fluid, follicular size, α2-macroglobulin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 B.A.M. has received an educational grant from Ferring. Y.S.W. has nothing to disclose. A.S.P. is a consultant for and has received research grants from Ferring, EMD Serono, and Organon. A.U. has nothing to disclose.

 Supported by an educational grant from Ferring Pharmaceuticals (Parsippany, New Jersey) and R01HL62958 to AU.

PII: S0015-0282(08)04647-5

doi:10.1016/j.fertnstert.2008.11.033

Fertility and Sterility
Volume 93, Issue 2 , Pages 537-543, 15 January 2010